Most luminal breast tumors express ERα and are dependent on estrogen signaling for growth and proliferation.65 Because ERα is known to control many essential growth pathways, including several metabolic pathways and amino acid transporters,66–68 we hypothesized that estrogen signaling might also promote ASCT2 expression and serine uptake. The gene discussed is SLC1A5; the disease is breast neoplasm.